EDF Health

Richard Denison, Ph.D., is a Lead Senior Scientist.

[Use this link to see all of our posts on Dourson.]

In testimony before the Senate Environment and Public Works Committee (EPW) on October 4 and in responses to Questions for the Record submitted by Senators after the hearing, Michael Dourson, the Trump Administration’s nominee to run EPA’s chemical safety program, provided information about his work on a DuPont chemical called PFOA (also known as C8) that is incomplete and misleading.  His selective responses to Senators’ questions reinforce the already serious concerns about his nomination and his suitability for the job.   Read More »

Richard Denison, Ph.D., is a Lead Senior Scientist.

[Use this link to see all of our posts on Dourson.]

Today a letter was submitted to the Senate Environment and Public Works Committee signed by more than 50 public health scientists from dozens of universities voicing their strong opposition to the nomination of Michael Dourson to lead the EPA Office of Chemical Safety and Pollution Prevention (OCSPP).

The scientists’ letter states, in part:

Granting Dr. Dourson the responsibility of overseeing EPA OCSPP would threaten the agency’s ability to credibly and effectively address harmful chemical exposures.  Dr. Dourson has built a career of abusing science to mischaracterize real-world chemical risks and in doing so has jeopardized public health, including the health of those most vulnerable among us like pregnant women and children.

The letter comes in advance of a vote on his nomination by the Senate Committee, currently scheduled for this Wednesday at 10am EDT.  If he is voted out of committee, a majority vote of the full Senate would then be required for his nomination to be confirmed.

Richard Denison, Ph.D., is a Lead Senior Scientist.

[My colleague Ryan O’Connell assisted in the research described in this post.]

[Use this link to see all of our posts on Dourson.]

In a series of earlier posts to this blog, we have described and documented numerous conflicts of interests that Michael Dourson, the Trump Administration’s nominee to head EPA’s toxics office, would bring to the job if he is confirmed.

(A vote on his nomination by the Senate Environment and Public Works Committee is currently scheduled for this Wednesday at 10am EDT.  If he is voted out of committee, a majority vote of the full Senate would then be required for his nomination to be confirmed.)

Dourson has worked on dozens of toxic chemicals under payment from dozens of companies.  Two consistent patterns emerge when his reviews are examined:  The process he typically uses to conduct his reviews is riddled with conflicts of interest.  And his reviews typically result in him recommending “safe” levels for the chemicals that are weaker, often much weaker, than the established standards in place at the time of his reviews.

If confirmed, Dourson would oversee most of the chemicals and companies he has worked on and with.  The chemicals include numerous pesticides coming up for review shortly under the Federal Insecticide, Fungicide and Rodenticide Act (FIFRA), as well as three chemicals that are among the first 10 EPA is now considering under the recently amended Toxic Substances Control Act (TSCA).

To further gauge the impact Dourson could have if confirmed, we have looked a bit farther down the road.  TSCA requires EPA to be conducting risk evaluations on at least 20 chemicals by December 2019.  At least half of those chemicals are to be drawn from EPA’s so-called Work Plan for Chemical Assessments.

Using information available on the website of Dourson’s company, Toxicology Excellence for Risk Assessment (TERA), as well as his published papers, we compared the list of chemicals he/TERA have worked on to those on the EPA Work Plan.  We found that 22 chemicals overlap.  We then examined each chemical Dourson or TERA worked on to determine whether Dourson or TERA was paid for their work by their manufacturers or industrial users of those chemicals.   Read More »